Resolving Behavioral Output via Chemogenetic Designer Receptors Exclusively Activated by Designer Drugs | Journal of Neuroscience
A Cre Driver Line for Genetic Targeting of Kappa Opioid Receptor Expressing Cells | eNeuro
A Cre Driver Line for Genetic Targeting of Kappa Opioid Receptor Expressing Cells | eNeuro
PDF) A New DREADD Facilitates the Multiplexed Chemogenetic Interrogation of Behavior
Frontiers | The Role of the Kappa Opioid System in Comorbid Pain and Psychiatric Disorders: Function and Implications
Dynorphin / kappa-opioid receptor regulation of excitation-inhibition balance toggles afferent control of prefrontal cortical circuits in a pathway-specific manner | Molecular Psychiatry
Psychoactives | Free Full-Text | The Role of the Dynorphin/Kappa Opioid Receptor System in the Actions of Alcohol
![PDF] Clozapine N-Oxide Administration Produces Behavioral Effects in Long–Evans Rats: Implications for Designing DREADD Experiments | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c7b09d4a79773b4f3d7b0fec2825409ca299dac6/5-Figure1-1.png "PDF] Clozapine N-Oxide Administration Produces Behavioral Effects in Long–Evans Rats: Implications for Designing DREADD Experiments | Semantic Scholar")
PDF] Clozapine N-Oxide Administration Produces Behavioral Effects in Long–Evans Rats: Implications for Designing DREADD Experiments | Semantic Scholar
Behavioral and Physiological Effects of a Novel Kappa-Opioid Receptor-Based DREADD in Rats | Neuropsychopharmacology
An Overview of Chemogenetics
Frontiers | Knock-In Mouse Models to Investigate the Functions of Opioid Receptors in vivo
The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice | Scientific Reports
Combining designer receptors exclusively activated by designer drugs and neuroimaging in experimental models: A powerful approach towards neurotheranostic applications - Peeters - 2020 - British Journal of Pharmacology - Wiley Online Library
Frontiers | Dynorphin/kappa opioid receptor system regulation on amygdaloid circuitry: Implications for neuropsychiatric disorders
![PDF] DREADDs for Neuroscientists | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cc7db00617d97220b2f596e27279d1b9ea9bcf59/2-Table1-1.png "PDF] DREADDs for Neuroscientists | Semantic Scholar")
PDF] DREADDs for Neuroscientists | Semantic Scholar
Receptor activated solely by a synthetic ligand - Wikipedia
New Technologies for Elucidating Opioid Receptor Function: Trends in Pharmacological Sciences
Clozapine N-Oxide Administration Produces Behavioral Effects in Long–Evans Rats: Implications for Designing DREADD Experiments | eNeuro
Usefulness of knockout mice to clarify the role of the opioid system in chronic pain - Maldonado - 2018 - British Journal of Pharmacology - Wiley Online Library
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Frontiers | Dynorphin/kappa opioid receptor system regulation on amygdaloid circuitry: Implications for neuropsychiatric disorders
Behavioral and Physiological Effects of a Novel Kappa-Opioid Receptor-Based DREADD in Rats | Neuropsychopharmacology
Kappa opioid receptor in nucleus accumbens regulates depressive-like behaviors following prolonged morphine withdrawal in mice - ScienceDirect
Kappa-opioid receptor stimulation in the nucleus accumbens shell: Differential effects across the rostro-caudal axis on dopamine transmission and affective behavior | bioRxiv
Modulating Dopamine Signaling and Behavior with Chemogenetics: Concepts, Progress, and Challenges | Pharmacological Reviews
The claustrum-prelimbic cortex circuit through dynorphin/κ-opioid receptor signaling underlies depression-like behaviors associated with social stress etiology | Nature Communications
